Sarepta Therapeutics, Inc.’s closest tracked peers in the AskCyborg corpus, with each peer’s Cyborg Score (1–10) from a bull-vs-bear AI analyst debate. Highest-scored: Ionis Pharmaceuticals (8/10), BioMarin Pharmaceutical (7/10), Ultragenyx Pharmaceutical (6/10).
| Competitor | Cyborg Score | Industry | Why they compete |
|---|---|---|---|
| Ionis Pharmaceuticals | 8/10 | Biopharmaceutical - RNA-Targeted Medicines & Gene Therapy | Antisense oligonucleotide technology for rare diseases |
| BioMarin Pharmaceutical | 7/10 | Biotechnology - Rare Disease Therapeutics | AAV gene therapies for rare genetic disorders |
| Ultragenyx Pharmaceutical | 6/10 | Biopharmaceutical - Rare and Ultra-Rare Genetic Disease Therapeutics | Rare genetic disease gene therapy and enzyme replacement |
| Solid Biosciences | 5/10 | Biotechnology | DMD gene therapy programs |
Read the full Sarepta Therapeutics, Inc. research report.
Cyborg Scores (1–10) are synthesized by AskCyborg’s multi-agent analyst-debate framework across 11 dimensions, recalibrated weekly. How the score works · Methodology.